WAIKOLOA, Hawaii — Francis W. Price, MD, and Marianne Price, PhD, MBA, were honored with the Philip M. Corboy, MD, Memorial Award and Lecture at Hawaiian Eye 2026.
The pair are the first couple to be honored with the lecture. Ric Tiplady, MBA, and Robert B. Miller, MD, presented them with the award.
“Dr. Marianne is a PhD in molecular genetics, and Dr. Frank is a corneal specialist who founded the Cornea Research Foundation of America,” Tiplady said. “Together, they have both documented and advanced endothelial keratoplasty.”
Francis Price thanked the audience for the award.
“I think we’re all

PHOENIX — Certain subsets of patients older than 60 years with isolated pelvic ring injuries may benefit from operative treatment, according to data presented at the Orthopaedic Trauma Association Annual Meeting.
“There is a lot of recent research that suggests certain subsets of these patients may benefit from operative treatment, and our data suggests that for these patients that can benefit from surgery, it is better to operate sooner rather than later,” Carol Lee, MD, PGY-5 resident at Cedars-Sinai Medical Center in Los Angeles, told Healio.
Lee and colleagues reviewed data from 321,305

WAIKOLOA, Hawaii — In this Healio Video Perspective from Retina 2026, Sharon Fekrat, MD, FACS, FASRS, of Duke University, discusses the current management of diabetic macular edema and diabetic retinopathy.
Fekrat examined second-generation anti-VEGF therapies, including Eylea HD (aflibercept 8 mg, Regeneron) and Vabysmo (faricimab-svoa, Genentech).
She also shared some take-home points.
“Early intervention in vision-threatening diabetic macular edema does prevent visual acuity loss,” Fekrat said. “Eyes with good vision and DME can be observed until they begin to worsen.”

When our practice adopted the Light Adjustable Lens in 2022, we did so with a clear purpose of helping patients with corneal irregularities achieve excellent refractive outcomes.
From patients with prior refractive surgery or corneal ectasia to those with anatomy poorly suited for multifocal optics, the Light Adjustable Lens (LAL, RxSight) is our problem-solving lens. We also recommend it for many patients with regular corneas, especially those interested in refractive lens exchange.
Our optometrists lead most of the LAL workflow. Patients are primarily in our care pre- and postoperatively.

Significantly more facilities prescribe single-fraction stereotactic body radiation therapy than they did 20 years ago, but a minimal number of individuals with non-small cell lung cancer actually receive it.
A retrospective analysis of more than 83,000 patients prescribed SBRT between 2006 and 2021 showed nearly 99% received multifraction treatment, compared with just over 1% who received single-fraction.
“Most radiation oncologists I know are deeply concerned about delivering lung SBRT in a single fraction,” Drew Moghanaki, MD, MPH, FASTRO professor and chief of thoracic oncology in the

WAIKOLOA, Hawaii — Using neutral language with patients and thorough documentation can help mitigate your practice’s legal risks when utilizing premium IOLs, according to a presenter.
“Don’t be afraid of the technology. We need to recommend what’s best for the patient,” Lisa M. Nijm, MD, JD, said during a presentation at Hawaiian Eye 2026. “Premium IOL risk is rarely about the lens — it’s about process, communication and documentation. Those are all within our control.”
Cataract surgery accounts for the highest legal claim volume in

The rate of heart disease-related deaths declined from 2022 to 2023, but cardiovascular disease remains the leading cause of mortality in the U.S. and globally, accounting for one death every 34 seconds, researchers found.
The prevalence of many CVD risk factors continued to increase year-over-year, including obesity and inadequate physical activity, sleep and BP control, whereas cigarette smoking has declined, according to the American Heart Association’s 2026 Statistical Update.
The document, designed to highlight the latest trends in CVD mortality and risk factors, was published in

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.
“We have developed a tool that can help clinicians (and primary care physicians in particular) integrate life expectancy and prostate cancer risk into a single estimate,” Patrick Lewicki, MD, MS, a clinical instructor at University of Michigan Medical School, told Healio.
According to Lewicki and colleagues, currently available risk calculators that predict prostate cancer on biopsy are useful but have multiple limitations.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, Jay S. Pepose, MD, PhD, of Pepose Vision Institute, discusses the impact of vitreous opacities.
{{VIDEO}}
Pepose urged anterior segment surgeons not to ignore the vitreous when dealing with patient complaints. He said one example is if patients report vision problems even if they have good high-contrast vision.
“They have complaints that vision seems veiled. It’s dim,” he said. “They see these moving shadows.”
Pepose said specialized testing, including quantitative ultrasound and widefield dynamic scanning laser

In the last decade, the growing disparity between declining professional fee CPT reimbursements and hospital-based contracting has led more orthopedists to choose hospital employment or practice service agreements with large health systems.
Work relative value units (wRVUs) remain the dominant framework for compensation, yet most procedural physicians, new and old, enter crucial negotiations with employers with little understanding of wRVUs, fair market value (FMV) or best practices for advocating for themselves.
In this month’s column, we aim to demystify wRVUs, highlight how specific